Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Neurology · Behavioral Variant Frontotemporal Dementia

Is Behavioral Variant FTD Hereditary? Genetic Risk Explained for Families

At a Glance

Behavioral variant frontotemporal dementia (bvFTD) is hereditary in some families but many cases occur without a known inherited cause. If a parent carries a disease-causing C9orf72, MAPT, or GRN mutation, each child has a 50% chance of inheriting it, but inheritance does not guarantee dementia.

If you or a loved one has been diagnosed with behavioral variant frontotemporal dementia (bvFTD), it is entirely natural to worry about what this means for your children.

The short answer is: bvFTD can be hereditary, but it is not always passed down.

A diagnosis of bvFTD alone does not automatically mean your children are at high risk. Between 20% and 50% of all frontotemporal dementia (FTD) cases are considered familial, meaning there is a pattern of the disease in the family history or a known genetic cause [1][2]. The rest are considered sporadic, occurring by chance without a clear genetic link. However, it is possible to carry a genetic mutation for the disease even if you do not have a known family history [3].

The Major Genetic Causes

Most known genetic cases of bvFTD are caused by mutations in one of three specific genes [4]:

  • C9orf72: This is the most common genetic cause of FTD. It is also strongly linked to amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease) [5]. The symptoms, the age they begin, and the severity can vary widely from person to person, even within the same family [6].
  • MAPT: Mutations in this gene lead to abnormal buildups of a protein called tau in the brain [4]. It is closely associated with bvFTD and sometimes movement issues similar to Parkinson’s disease (parkinsonism).
  • GRN: Mutations in this gene affect a protective protein called progranulin, which is associated with the buildup of another protein (TDP-43) in the brain [4].

While these three genes are the most common, researchers have identified several other, rarer genes linked to FTD, and some families with clear inheritance patterns have no identifiable mutation yet [1].

Understanding Autosomal Dominant Inheritance

When bvFTD is caused by a mutation in C9orf72, MAPT, or GRN, it usually follows an autosomal dominant inheritance pattern.

If a parent is confirmed through genetic testing to have one of these disease-causing mutations, each biological child has a 50% chance of inheriting that specific mutation [7]. It is similar to flipping a coin. If a child does not inherit the familial mutation, they cannot pass that specific mutation on to their future children.

Importantly, inheriting a mutation does not mean a 100% guarantee of developing dementia. This concept is called penetrance—the proportion of people with a genetic variant who actually develop symptoms over their lifetime. Especially with the C9orf72 gene, penetrance is age-related and can be incomplete, meaning some people with the gene may never develop symptoms, or may develop them at a completely different age than their parent did [6].

Testing Strategy: What the Results Mean

If you are concerned about your children’s risk, medical guidelines recommend that the person who already has bvFTD be tested first, rather than testing the children directly [8]. This is the most informative way to find out if a hereditary gene is present in the family.

Testing the affected person can yield three types of results [8]:

  • Positive (Pathogenic Variant): A known disease-causing mutation is found. If this happens, adult children can then decide if they want to undergo “predictive testing” to see if they inherited the specific gene.
  • Negative: No known mutations are found. This is reassuring, but it does not completely rule out a genetic cause because science has not yet discovered every gene responsible for FTD.
  • Variant of Uncertain Significance (VUS): A genetic change is found, but doctors do not currently know if it causes disease. A VUS should not be used to predict a child’s risk, make reproductive decisions, or alter medical care.

The Vital Role of Genetic Counseling

Because of the heavy emotional weight and uncertainty involved, you should meet with a genetic counselor before pursuing testing [8][9]. A genetic counselor helps your family navigate:

  • Choosing the Right Test: Standard genetic panels might miss certain mutations (like the C9orf72 “repeat expansion”), so specialized testing is often required [8].
  • Emotional and Social Impact: Knowing you carry a gene for dementia can profoundly affect your self-image, relationships, and anxiety levels, even if it helps with future planning [10]. Negative results can bring relief, but the waiting process is stressful.
  • Family Dynamics: Predictive testing for adult-onset conditions is completely voluntary. It is up to each adult child to decide if, and when, they want to know their genetic status. Testing minors for adult-onset diseases is generally not recommended.
  • Insurance and Privacy Considerations: While laws in some countries protect your health insurance and employment from genetic discrimination, these protections often do not apply to life insurance, disability insurance, or long-term care insurance.
  • Family Planning: For families who want to know, counselors can discuss reproductive options, such as in vitro fertilization (IVF) with genetic testing of embryos, to prevent passing a known mutation to the next generation.

Common questions in this guide

Is behavioral variant frontotemporal dementia hereditary?
Sometimes. About 20% to 50% of frontotemporal dementia cases are familial because of a family pattern or known genetic cause, while many cases occur without a clear inherited link. A genetic mutation can still be present even when no family history is known.
What is the chance that a child will inherit a bvFTD mutation?
If a parent has a confirmed disease-causing mutation in C9orf72, MAPT, or GRN, each biological child has a 50% chance of inheriting that specific mutation. Not inheriting the family mutation means the child cannot pass that specific mutation to future children.
Does inheriting a bvFTD mutation guarantee that someone will develop dementia?
No. Inheriting a disease-causing mutation does not always lead to dementia because some mutations have incomplete, age-related penetrance. Symptoms may never develop or may begin at a different age than they did in a parent.
Which genes are most often linked to hereditary bvFTD?
The three most common genes linked to genetic frontotemporal dementia are C9orf72, MAPT, and GRN. C9orf72 is also strongly associated with amyotrophic lateral sclerosis, while MAPT and GRN are linked to distinct protein changes in the brain.
Who should be tested first when bvFTD may run in a family?
The family member who already has bvFTD should usually be tested first because this gives the most informative result. Testing should be discussed with a genetic counselor, and adult children can consider voluntary predictive testing if a familial disease-causing mutation is identified.
What does a negative or uncertain genetic test mean for my family?
A negative result means that no currently known disease-causing mutation was found, but it does not completely rule out a genetic cause. A variant of uncertain significance should not be used to predict a child’s risk, guide reproductive decisions, or change medical care.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my symptoms and family history, do you recommend I undergo genetic testing for FTD?
  2. 2.Can you refer us to a genetic counselor who specializes in neurodegenerative diseases?
  3. 3.If we proceed with testing, does the specific panel you use explicitly check for the C9orf72 repeat expansion?
  4. 4.If my genetic test is negative, how does that change the estimated risk for my children?
  5. 5.Are there any clinical trials or observational studies for genetic forms of bvFTD that my family might qualify for?
  6. 6.How should I approach discussing my genetic test results with my adult children?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Genetics of Frontotemporal Dementia.

    Olszewska DA, Lonergan R, Fallon EM, Lynch T

    Current neurology and neuroscience reports 2016; (16(12)):107 doi:10.1007/s11910-016-0707-9.

    PMID: 27878525
  2. 2

    C9orf72 expansions are the most common cause of genetic frontotemporal dementia in a Southeast Asian cohort.

    Tan YJ, Yong ACW, Foo JN, et al.

    Annals of clinical and translational neurology 2023; (10(4)):568-578 doi:10.1002/acn3.51744.

    PMID: 36799407
  3. 3

    Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases.

    Ramos EM, Dokuru DR, Van Berlo V, et al.

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2020; (16(1)):118-130 doi:10.1002/alz.12011.

    PMID: 31914217
  4. 4

    Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells.

    Lines G, Casey JM, Preza E, Wray S

    Molecular and cellular neurosciences 2020; (109()):103553 doi:10.1016/j.mcn.2020.103553.

    PMID: 32956830
  5. 5

    Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.

    Shi Y, Lin S, Staats KA, et al.

    Nature medicine 2018; (24(3)):313-325 doi:10.1038/nm.4490.

    PMID: 29400714
  6. 6

    C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients.

    König T, Wurm R, Parvizi T, et al.

    Neurobiology of disease 2022; (175()):105927 doi:10.1016/j.nbd.2022.105927.

    PMID: 36379394
  7. 7

    The shared ancestry between the C9orf72 hexanucleotide repeat expansion and intermediate-length alleles using haplotype sharing trees and HAPTK.

    Rautila OS, Kaivola K, Rautila H, et al.

    American journal of human genetics 2024; (111(2)):383-392 doi:10.1016/j.ajhg.2023.12.019.

    PMID: 38242117
  8. 8

    Alzheimer's Disease and Frontotemporal Dementia: The Current State of Genetics and Genetic Testing Since the Advent of Next-Generation Sequencing.

    Goldman JS, Van Deerlin VM

    Molecular diagnosis & therapy 2018; (22(5)):505-513 doi:10.1007/s40291-018-0347-7.

    PMID: 29971646
  9. 9

    Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Impact on Clinical Management.

    Roggenbuck J, Fong JC

    Clinics in laboratory medicine 2020; (40(3)):271-287 doi:10.1016/j.cll.2020.05.002.

    PMID: 32718499
  10. 10

    "It seems enormously valuable to me." Perspectives of Dutch (potential) carriers of genetic FTD on onset-predictive biomarker testing.

    Graafland CH, Seelaar H, Panman JL, et al.

    Alzheimer's research & therapy 2025; (17(1)):99 doi:10.1186/s13195-025-01749-z.

    PMID: 40329303

This page explains hereditary risk and genetic testing in bvFTD for informational purposes only and does not constitute medical advice. Discuss your family’s situation with a neurologist and genetic counselor.

Get notified when new evidence is published on Behavioral variant of frontotemporal dementia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.